Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences.
AUTOR(ES)
Mendelson, J
RESUMO
Herpes genitalis is an infection associated with considerable morbidity. Acyclovir, though effective, must be taken daily to prevent recurrences. The effects of interferon on this infection were therefore investigated. In a randomised double blind study, 31 patients with first episodes of genital herpes infection were studied to assess the effect of interferon on the presenting episode and on recurrences. Interferon (5 X 10(6) IU) was administered once daily subcutaneously during a five day "treatment" period followed by a three month "maintenance" period (1 X 10(6) IU three times weekly). Interferon had no effect on first episode herpetic attacks. During interferon administration women showed a trend towards reduced healing time and viral shedding in recurrences, but the differences were not significant and no effect was noted in women after administration of interferon. Interferon reduced assessed healing time and viral shedding in recurrences, however, in men (p = 0.05) during interferon administration, and this continued as a trend after treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1011908Documentos Relacionados
- Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.
- Acyclovir in first attacks of genital herpes and prevention of recurrences.
- A prospective study of the psychological impact on patients with a first episode of genital herpes.
- Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes.
- Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes.